Bivamelagon (LB54640) is an orally bioavailable agonist that selectively binds and activates the melanocortin-4 receptor in the brain, a receptor involved in regulating hunger, satiety and energy expenditure. It is being studied for hypothalamic obesity.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.